Quentis Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 28, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $48,000,000
Company Info
- Company Description
- Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.
- Market
- Cancer Immunotherapy
- Location
- New York, New York, USA
- Coinvestors
- AbbVie Biotech Ventures, Alexandria Real Estate Equities, New York Ventures, Polaris Partners, Taiho Ventures, Versant Ventures, Yonghua Capital